Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
OncoSpear ApS
APS
Active
Reklamebeskyttelse
CVR 42093734
Lucernevej 2, 8382
Hinnerup
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2021 · 5 years old
8 employees
Overvåg
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
OncoSpear ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2021
-1M
2022
-5M
2023
-5M
2024
EBITDA
DKK millions
0M
-3M
-5M
-8M
-10M
0M
2021
-1M
-100%
2022
-8M
-700%
2023
-8M
0%
2024
Income statement
DKK thousands
Item
2021
2022
2023
2024
Gross profit
-26
-640
-5.396
-4.652
Staff expenses
-0
-588
-2.751
-3.389
EBITDA
-26
-1.228
-8.147
-8.041
Depreciation & amort.
-0
-0
-0
-0
EBIT
-26
-1.228
-8.147
-8.041
Net financials
-0
-0
-0
-4
Profit before tax
-26
-1.228
-8.147
-8.045
Tax
-0
-138
-1.452
-1.584
Net profit
-26
-1.090
-6.694
-6.461
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
Total assets
33
7.510
9.253
3.251
Equity
24
7.112
7.853
1.392
Long-term debt
0
0
0
676
Short-term debt
10
397
1.400
1.183
Total debt
10
397
1.400
1.859
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
-804136000.0%
This company
2021
2024
Soliditetsgrad
42.8%
This company
38.2%
Market median
+12% vs market
2021
2024
Egenkapitalforrentning
-464.3%
This company
18.4%
Market median
-2623% vs market
2021
2024
Nettoresultatgrad (af bruttofortjeneste)
-646113900.0%
This company
2021
2024
Aktivomsætning (af bruttofortjeneste)
-1.43×
This company
2021
2024
Gæld/egenkapital
1.34×
This company
0.62×
Market median
-116% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-02-01 – 2021-12-31
View
PDF
More on OncoSpear ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
